Archives of Gerontology and Geriatrics Plus · Apr 5, 2026
Divergent mortality associated with Parkinson’s disease dementia in the United States from 1999 to 2020
By Kumar D, Kalpina F, Shujaat T et al.
ABSTRACT Background Dementia, a late-stage manifestation of Parkinson’s disease (PD), predominantly affects older adults. However, national trends and subgroup disparities in mortality among PD co-occurring dementia remain underexplored. This study aimed to evaluate temporal and demographic patterns of Dementia in PD-related mortality in the United States from 1999 to 2020. Methods We conducted a retrospective analysis using CDC WONDER Multiple Cause-of-Death data for adults aged ≥65 years, identifying Dementia in PD through ICD-10 codes G20 and F01,F03,G30 as ICD-10 does not include a specific code for PDD. Age-adjusted mortality rates per 100,000 were standardized to the 2000 U.S. population. Joinpoint regression estimated annual and average annual percent changes with 95% confidence intervals. Results A total of 234,377 PD concomitant with dementia-related deaths were recorded. Overall AAMR rose significantly from 1999 to 2001 (APC = 25.95; 95% CI 12.06–37.38), plateaued until 2018, and increased again through 2020 (APC = 11.21; 95% CI 2.49–15.71; AAPC = 3.04; 95% CI 2.33–3.86). Mortality was higher in men (36.61) than women (18.83), particularly among those aged ≥85 years (88.84). Non-Hispanic Whites had the highest AAMR (27.63), followed by Hispanics (19.48) and Non-Hispanic Blacks (15.47). Regionally, the Midwest exhibited the highest rates (28.87), with non-metropolitan areas (27.03) exceeding metropolitan ones (25.43). Conclusion Dementia in PD-related mortality in the U.S. has risen notably, especially since 2018. Men, the oldest adults, Non-Hispanic Whites, and residents of rural or Midwestern regions face the greatest risk, emphasizing the need for targeted prevention, early diagnosis, and equitable neurologic care.